Glass, B;Ziepert, M;Reiser, M;Freund, M;Trümper, L;Metzner, B;Feller, A;Loeffler, M;Pfreundschuh, M;Schmitz, N;German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL);Feller, AC;Hansmann, ML;Müler-Hermelink, HK;Moeller, P;Parwaresch, R;Stein, H;Glass, B;Schmitz, N;Schnabel, K;Rübe, C;Loeffler, M;Ziepert, M;Mann, B;Schoenwiese, U;Martin Montanez, L;Roskothen, M;Keil, C;Kunert, M;Wicklein, B;Döken, B;Schmiegel, W;Vetter, H;Pflüer, K;Steinhauer, H;Trüper, L;Eimermacher, H;Schmitz, N;Balleisen, L;Pfreundschuh, M;Fauser, A;Link, H;Fischer, J;Kneba, M;Hallek, M;Wagner, T;Graeven, U;Peschel, C;Schlödorff, D;Lutz, L;Berdel, W;Metzner, B;Pasold, R;Freund, M;Gassmann, W;Heidemann, E;Mergenthaler, H;Köbel, C;Frickhofen, N;Wilms, K.High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma..Ann Oncol.2010.21.11.2255-61